Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1945 - 1952 of 11616 results
High Risk, No Reward: SEC’s First Reg BI Enforcement Action
June 21, 2022| Blog| Viewpoint
Digital Health Companies Hit With Securities Fraud Suits
June 20, 2022| News
Vet Clinic FTC Settlement Puts Private Equity On Notice
June 17, 2022| Blog| Viewpoint
In Honor of Juneteenth: Bob Bodian’s Address to Colleagues
June 17, 2022| Blog| Viewpoint
The Supreme Court Strikes a Blow to PAGA: What California Employers Need to Know
June 16, 2022| Blog| Viewpoint
Private Equity On Notice Due To Vet Clinic FTC Settlement
June 16, 2022| News
Remote-Controlled Robotics
June 15, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.